Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices 43547 

approved for the 2014 revision. This 

reflects both a slight decrease in the 

anticipated number of Health Hazard 

Evaluation requests (300 to 290) as well 

as changes in the response requirements 

of requests received based upon recent 

program experience. 

Type of respondent Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Employees/employee representatives/or employers.Health Hazard Evaluation Request Form ...... 290 1 12/60 

Employees ...................................................... Health Hazard Evaluation specific interview 

example.

2,580 1 15/60 

Employees ...................................................... Health Hazard Evaluation specific questionnaire example.3,700 1 30/60 

Employees ...................................................... Employee Contact Postcard .......................... 2,150 1 5/60 

Follow-back for onsite evaluations—employer 

& employee representative Year 1.

Initial Site Visit Followback Survey form ........ 244 1 10/60 

Employer & employee representative Year 1 Closeout for Health Hazard Evaluation 

Followback Survey with site visit.

244 1 20/60 

Employer & employee representative Year 2 1 Year Later for Health Hazard Evaluation 

Followback Survey with site visit.

244 1 15/60 

Follow-back for evaluations without onsite— 

employer & employee representative Year 

1.

Closeout for Health Hazard Evaluation without site visit.98 1 10/60 

Employer & employee representative Year 2 1 Year Later for Health Hazard Evaluation 

without site visit.

98 1 15/60 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–19744 Filed 9–15–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC)—Health Disparities 

Subcommittee (HDS) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Committee to the Director, Centers for 

Disease Control and Prevention—Health 

Disparities Subcommittee (ACD, CDC– 

HDS). This meeting is open to the 

public, limited only by the room that 

accommodates 45 people and audio 

phone line that accommodates 50 

callers. The public is also welcome to 

listen to the meeting by dialing 866– 

918–8397 and enter code 9346283, this 

conference line is available to the first 

50 callers. The public comment period 

is from 9:45 a.m. to 9:50 a.m. and 3:45 

p.m. to 3:55 p.m. The deadline to 

register for in-person attendance and/or 

notice of intent to make oral or written 

comment is October 30, 2017. To 

register, please send an email to 

ACDirector@cdc.gov. 

DATES: The meeting will be held on 

November 9, 2017, 8:30 a.m. to 4:00 

p.m. ET. 

ADDRESSES: CDC, Building 21, 12th 

Floor, Rooms 12105–12101, 1600 

Clifton Road NE., Atlanta, Georgia 

30329. 

Bridge line: 866–918–8397 and enter 

code 9346283. 

FOR FURTHER INFORMATION CONTACT: 

Leandris Liburd, Ph.D., M.P.H., M.A., 

Designated Federal Officer, Health 

Disparities Subcommittee, Advisory 

Committee to the Director, CDC, 1600 

Clifton Road NE., M/S K–77, Atlanta, 

Georgia 30329. Telephone (404) 498– 

6482, Email: ACDirector@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Subcommittee will 

provide counsel to ACD, CDC on 

strategic and other health disparities 

and health equity issues and provide 

guidance on opportunities for CDC. 

Matters to be Considered: The Health 

Disparities Subcommittee Agenda will 

include discussions on addressing 

health disparities in achieving the 

agency’s overarching health impact 

goals including selected observations 

from the HDS for the ACD, CDC to 

consider, and on progress of the HDS, 

and on progress toward activities related 

to data disaggregation and childhood 

trauma. Agenda items are subject to 

change as priorities dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2017–19779 Filed 9–15–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), announces the 

following meeting for the Healthcare 

Infection Control Practices Advisory 

Committee (HICPAC). This meeting is 


sradovich on DSKBBY8HB2PROD with NOTICES
43548 Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices 

open to the public, limited only by room 

seating available. The public is also 

welcome to listen to the meeting by 

866–836–4010, passcode: 18307719, 

and, and 100 teleconference lines are 

available. 

DATES: The meeting will be held on 

November 8, 2017, 9:00 a.m. to 5:00 

p.m., EST and November 9, 2017, 9:00 

a.m. to 12:00 p.m., EST. 

ADDRESSES: Centers for Disease Control 

and Prevention, Global Communications 

Center, Building 19, Auditorium B, 1600 

Clifton Road NE., Atlanta, Georgia 

30329. 

FOR FURTHER INFORMATION CONTACT: Erin 

Stone, M.A., HICPAC, Division of 

Healthcare Quality Promotion, NCEZID, 

CDC, l600 Clifton Road NE., Mailstop 

A–07, Atlanta, Georgia 30329, 

Telephone (404) 639–4045, Email: 

hicpac@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Director, Division of Healthcare 

Quality Promotion (DHQP), the Director, 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

the Director, CDC, the Secretary, Health 

and Human Services regarding (1) the 

practice of healthcare infection 

prevention and control; (2) strategies for 

surveillance, prevention, and control of 

infections, antimicrobial resistance, and 

related events in settings where 

healthcare is provided; and (3) periodic 

updating of CDC guidelines and other 

policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters to be Considered: The agenda 

will include updates on CDC’s activities 

for prevention of healthcare associated 

infections (HAIs), and DHQP’s modeling 

efforts. It will also include updates from 

the following HICPAC workgroups: The 

Guideline for Prevention of Infection in 

Neonatal Intensive Care Unit (NICU) 

Patients; the Guideline for Prevention of 

Infection in Healthcare Personnel; the 

workgroup on updating the CDC 

recommendation categorization scheme; 

the workgroup on developing CDC 

recommendations for products and 

practices; and the National Healthcare 

Safety Network (NHSN) Surveillance 

Workgroup. 

Agenda items are subject to change as 

priorities dictate. 

Time will be available for public 

comment. The public is welcome to 

submit written comments in advance of 

the meeting. Comments should be 

submitted in writing by email to the 

contact person listed below. The 

deadline for receipt is October 25, 2017. 

All requests must contain the name, 

address, and organizational affiliation of 

the speaker, as well as the topic being 

addressed. Written comments should 

not exceed one single-spaced typed page 

in length and delivered in 3 minutes or 

less. Members of the public who wish 

to provide public comments should 

plan to attend the public comment 

session at the start time listed. Please 

note that the public comment period 

may end before the time indicated, 

following the last call for comments. 

Written comments received in advance 

of the meeting will be included in the 

official record of the meeting. 

Registration is required to attend in 

person or on the phone. Interested 

parties may register at www.cdc.gov/ 

hicpac. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2017–19778 Filed 9–15–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10292 and 

CMS–R–148] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by October 18, 2017. 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: OMB, Office of 

Information and Regulatory Affairs, 

Attention: CMS Desk Officer, Fax 

Number: (202) 395–5806 OR Email: 

OIRA_submission@omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

Web site address at https://

www.cms.gov/Regulations-andGuidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing.html. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 


sradovich on DSKBBY8HB2PROD with NOTICES